Last deal

$1.5M

Amount

Series B

Stage

23.05.2003

Date

1

all rounds

$1.5M

Total amount

date founded

Financing round

General

About Company
Quantum Dot Corporation (QDC) develops and markets innovative biomolecular detection solutions.

Industry

Sector :

Subsector :

founded date

01.01.1971

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

QDC, a bioscience company founded in 1998 by Joel Martin and headquartered in Hayward, California, specializes in the development and commercialization of cutting-edge biomolecular detection solutions. Their flagship product, Qdot nanocrystals, utilizes quantum dot particles and semiconductor crystals to assist clinics in accurate biomolecular detection for clinical applications. With a focus on clinical applications, Quantum Dot Corporation aims to revolutionize the field of biomolecular detection with their advanced technology.
Contacts

Social url

Similar Companies
209
Tethis S.p.A

Tethis S.p.A

Tethis is a company that focuses on spreading innovation in the Nano- and Biotechnology fields.

Sector

Chemicals

Subsector

Specialty Chemicals

Keywords

Biotechnology, Health Care, Nanotechnology

Location

Milan, Metropolitan City of Milan, Italy

total rounds

7

total raised

$85.65K
IatroQuest Corporation

IatroQuest Corporation

IatroQuest Corporation develops biosensing modules for medical, defense, and environmental monitoring applications.

Sector

Chemicals

Subsector

Specialty Chemicals

Location

Ottawa, ON, Canada

total rounds

2

total raised

$11.27M
Core Quantum Technologies

Core Quantum Technologies

Core Quantum Technologies specializes in illuminating cell biology and pathology through the use of micelle-encapsulated nanocrystals.

Sector

Chemicals

Subsector

Specialty Chemicals

Keywords

Biotechnology, Nanotechnology, Health Care

Location

Columbus, OH, USA

total rounds

4

total raised

$1.42M
Aligned Bio

Aligned Bio

Aligned Bio develops advanced nanowire biosensor platforms for various applications.

Sector

Chemicals

Subsector

Specialty Chemicals

Location

Lund, Sweden

total rounds

5

total raised

$5.7M
M&A Details
1

Acquired by

Invitrogen Corporation

announced date

06.10.2005

Financials

Funding Rounds
1
1

Number of Funding Rounds

$1.5M

Money Raised

Their latest funding was raised on 23.05.2003. Their latest investor Abingworth. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
23.05.2003
4
$1.5M
Co-Investors
Investors
4
0

Number of lead investors

4

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series B
No
Series B
No
Series B
Abingworth

Abingworth

Abingworth collaborates with entrepreneurs to develop impactful health products in life sciences.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital

Location

London, UK

count Of Investments

131

count Of Exists

45
Schroder Ventures

Schroder Ventures

Schroders is a global investment manager serving institutions, intermediaries, and individuals globally.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

London, UK

count Of Investments

31

count Of Exists

19
MPM Capital

MPM Capital

MPM Capital invests in early-stage healthcare companies developing innovative oncology technologies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

count Of Investments

212

count Of Exists

66

People

Founders
1
Joel Martin, Ph.D.
Joel Martin, Ph.D.

Joel Martin, Ph.D.

Joel Martin is the Managing Director and Chief Business Officer of La Jolla Institute for Immunology. He attended University of Michigan - Stephen M. Ross School of Business.

current job

La Jolla Institute for Allergy & Immunology
La Jolla Institute for Allergy & Immunology

Joel Martin, Ph.D.

Employee Profiles
10
Joel Martin, Ph.D.

Joel Martin, Ph.D.

Co-Founder and CEO

Sunil Gulati

Tax

Activity

Recent News
0